IPO - I-Mab

Form Type: 424B5

Filing Date: 2025-07-11

Corporate Action: Ipo

Type: Update

Accession Number: 000119312525158201

Filing Summary: This Amendment No. 1 to Prospectus, dated July 11, 2025, updates the previously filed prospectus dated May 15, 2025, relating to the offer and sale of American Depositary Shares (ADSs) representing ordinary shares of I-Mab. The amendment concerns an increase in the maximum aggregate amount of ADSs that the company is eligible to sell under the prospectus, from $21,000,000 to $50,000,000. As of the date of this amendment, no ADSs have been sold under the sales agreement with Leerink Partners LLC, which was entered into on May 2, 2025. The ADSs are listed on the Nasdaq Global Market under the ticker symbol 'IMAB'. Additionally, the document emphasizes the risks involved in investing in these securities, urging investors to consider the risks and uncertainties outlined in the prospectus. It clarifies that the SEC and any state securities commissions have not approved or disapproved the securities or the adequacy of the prospectus, warning that any contrary statement is a criminal offense.